Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Clinical trial NCT00569673 · COMPLETED

Trial details

NCT number

NCT00569673

Sponsor

Gynecologic Oncology Group

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2008-03-01

Primary completion

2012-01-01

Enrollment

71

View on ClinicalTrials.gov